StimLabs launches second umbilical cord derived product: Corplex P
A dehydrated Wharton's Jelly tissue allograft designed to supplement connective tissue voids
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Aug 20
A dehydrated Wharton's Jelly tissue allograft designed to supplement connective tissue voids
27 Aug 20
The company will grant exclusive rights for the use of its ProteusPLUS technology to CGNNT and its subsidiary…
21 Aug 20
Qualigen Therapeutics is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious…
An Israeli research team's efforts to develop a neural network model for its robotic arm have been boosted…
The ReSound ONE hearing aid is the first technology of its kind to feature an additional microphone picking…
18 Aug 20
NuEra Tight with FocalRF technology will help deliver tailored body treatments to a patient's particular requirements
17 Aug 20
Regiocit is a citrate-based replacement solution designed for use in continuous renal replacement therapy (CRRT) during Covid-19 pandemic
17 Aug 20
The need to have robust risk mitigation plans for supply chains has given rise to companies increasingly favouring…
The IGNITE American Innovation Act has been introduced to the US House of Representatives and, if passed, will…
07 Aug 20
Rx3000® FDA certified Class II Medical device inactivates 99.97% of harmful airborne viruses & bacteria, including coronavirus strains,…